Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Assets (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Assets for 14 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 1.0% increase, with the full-year FY2025 number at 0.01%, up 3.0% from a year prior.
  • Return on Assets was 0.0% for Q4 2025 at Aytu Biopharma, down from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2025 to a low of 0.71% in Q2 2022.
  • A 5-year average of 0.19% and a median of 0.1% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -34bps in 2022, then skyrocketed 59bps in 2023.
  • Aytu Biopharma's Return on Assets stood at 0.26% in 2021, then tumbled by -104bps to 0.53% in 2022, then surged by 84bps to 0.09% in 2023, then surged by 87bps to 0.01% in 2024, then surged by 108bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Return on Assets are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).